ACTRN12610000540011Completed未知
The prevalence of persistent cough, upper airway dysfunction and voice disorders following H1N1 infection within the Newcastle area community.
Hunter New England Area Health Service0 sites100 target enrollmentStarted: July 6, 2010Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 8 Years to 80 Years (—)
- Sex
- All
Inclusion Criteria
- •Prior swab for H1N1 infection.
- •Persistent cough of more than 8 weeks duration.
- •All persons tested for H1N1 infection from the Hunter Area Pathology database will be invited to take in the questionnaire stage of the study (visit 1, adults and children) then a subset group of 50 subjects in each group (cases/controls) will be taken to physical testing stage (visit 2, adults only).
- •Informed consent must be obtained prior to commencement of the study.
Exclusion Criteria
- •Pregnancy/breast feeding
- •Other active respiratory disease such as Chronic Obstructive Pulmonary Disease (COPD), bronchiectasis, etc.
- •Inability to attend study visit/s.
Investigators
Similar Trials
Completed
Not Applicable
Comparison of effect of honey with cough syrups containing dextromethorphan and codeine on cough associated with upper respiratory tract infection in adults: a randomized trialCough associated with Upper respiratory tract infectionsRespiratory - Other respiratory disorders / diseasesAlternative and Complementary Medicine - Other alternative and complementary medicineACTRN12613000817741Safia Bano (Principal investigator)86
Completed
Not Applicable
A survey for the prevalence of chronic cough after recovery from COVID-19COVID-19JPRN-UMIN000046188Aichi Hospital170
Unknown
Not Applicable
Recurrent chronic cough, wheeze triggered by RS virus infection and their control with leukotriene receptor antagonists (LTRAs: montelukast, pranlukast), carbocystein and ambroxolRecurrent chronic cough, wheeze triggered by RS virus infection during early childhoodJPRN-UMIN000024787Department of Pediatrics, Hiroshima City Hospital50
Active, not recruiting
Phase 1
'Studies in patients with chronic cough; montelukast and amitriptyline studies’. - chronic cough studies.Chronic cough ( cough lasting > 8 weeks).EUCTR2006-005533-38-NLthere is no sponsor.
Unknown
Phase 4
Montelukast for Persistent Cough in Young People and AdultsPersistent CoughWhooping CoughNCT01279668University of Oxford276